Your browser doesn't support javascript.
loading
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial.
Heo, Jeong; Liang, Ja-Der; Kim, Chang Won; Woo, Hyun Young; Shih, I-Lun; Su, Tung-Hung; Lin, Zhong-Zhe; Yoo, So Young; Chang, Stanley; Urata, Yasuo; Chen, Pei-Jer.
Afiliação
  • Heo J; Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. Electronic address: jheo@pusan.ac.kr.
  • Liang JD; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Kim CW; Department of Radiology, College of Medicine, Pusan National University, Busan, Republic of Korea.
  • Woo HY; Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
  • Shih IL; Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
  • Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lin ZZ; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Yoo SY; BIO-IT Foundry Technology Institute, Pusan National University, Busan, Republic of Korea.
  • Chang S; Medigen Biotechnology Corp., Taipei, Taiwan.
  • Urata Y; Oncolys Biopharma Inc., Tokyo, Japan.
  • Chen PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: peijerchen@ntu.edu.tw.
Mol Ther ; 31(7): 2077-2088, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37060176

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Telomerase / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Hepáticas Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Telomerase / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Hepáticas Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article